• Mashup Score: 11
    Visa Wizard - 5 day(s) ago

    × You are about to leave travel.state.gov for an external website that is not maintained by the U.S. Department of State. Links to external websites are provided as a convenience and should not be construed as an endorsement by the U.S. Department of State of the views or products contained therein. If you wish to remain on travel.state.gov, click the “cancel” message. Privacy | Copyright & Disclaimer | FOIA | No FEAR Act Data | Office of the Inspector General | USA.gov | USA.gov/espanol | This site is

    Tweet Tweets with this article
    • Planning on traveling to the U.S. for #ASH24? Find out if your country requires a visa: https://t.co/4WNfqPN9ci If so, here's 4⃣ things you need to know before arranging your trip 👇 https://t.co/vNNwEs6M1S

  • Mashup Score: 3

    Give the high rate of advances in the field of clinical hematology, the IACH News initiative enables experts in the field and key opinion leaders share the most up to date information in a timely manner, and in a format that is, focused, engaging and easy to access. December 3rd 2024- Prof. Gili Kenet- Gene Therapy for Hemophilia November 17th 2024- Dr. Sarah Elitzur- ATM germline pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies November 11th

    Tweet Tweets with this article
    • RT @Mohty_EBMT: https://t.co/GTxBPDbeka #ASH24 ⁦@VincentRK⁩ ⁦@thanosdimop⁩ ⁦@ASH_hematology⁩ ⁦@Mohty_EBMT⁩ https://t.co/jlJjirFtCz

  • Mashup Score: 3

    Give the high rate of advances in the field of clinical hematology, the IACH News initiative enables experts in the field and key opinion leaders share the most up to date information in a timely manner, and in a format that is, focused, engaging and easy to access. December 3rd 2024- Prof. Gili Kenet- Gene Therapy for Hemophilia November 17th 2024- Dr. Sarah Elitzur- ATM germline pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies November 11th

    Tweet Tweets with this article
    • RT @Mohty_EBMT: https://t.co/GTxBPDbeka #ASH24 ⁦@VincentRK⁩ ⁦@thanosdimop⁩ ⁦@ASH_hematology⁩ ⁦@Mohty_EBMT⁩ https://t.co/jlJjirFtCz

  • Mashup Score: 3

    Give the high rate of advances in the field of clinical hematology, the IACH News initiative enables experts in the field and key opinion leaders share the most up to date information in a timely manner, and in a format that is, focused, engaging and easy to access. December 3rd 2024- Prof. Gili Kenet- Gene Therapy for Hemophilia November 17th 2024- Dr. Sarah Elitzur- ATM germline pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies November 11th

    Tweet Tweets with this article
    • RT @Mohty_EBMT: https://t.co/GTxBPDbeka #ASH24 ⁦@VincentRK⁩ ⁦@thanosdimop⁩ ⁦@ASH_hematology⁩ ⁦@Mohty_EBMT⁩ https://t.co/jlJjirFtCz

  • Mashup Score: 3

    Give the high rate of advances in the field of clinical hematology, the IACH News initiative enables experts in the field and key opinion leaders share the most up to date information in a timely manner, and in a format that is, focused, engaging and easy to access. December 3rd 2024- Prof. Gili Kenet- Gene Therapy for Hemophilia November 17th 2024- Dr. Sarah Elitzur- ATM germline pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies November 11th

    Tweet Tweets with this article
    • RT @Mohty_EBMT: https://t.co/GTxBPDbeka #ASH24 ⁦@VincentRK⁩ ⁦@thanosdimop⁩ ⁦@ASH_hematology⁩ ⁦@Mohty_EBMT⁩ https://t.co/jlJjirFtCz

  • Mashup Score: 1

    SAN DIEGO — Insurers rejected one-third of new prescriptions for specialty oral anticancer medications ordered for patients with blood cancers, according to retrospective data presented at ASH Annual Meeting and Exposition. Patients with commercial insurance and Medicaid had prescriptions rejected more often than patients with Medicare.“When the new high-cost cholesterol-lowering

    Tweet Tweets with this article
    • Healio spoke with the Leon Hess professor of internal medicine at @PennMedicine about data showing that insurers rejected one-third of new prescriptions for specialty oral anticancer medications ordered for patients with blood cancers. #ASH24 https://t.co/cto1tFPFLg

  • Mashup Score: 8

    Join the world’s leading hematology experts at Highlights of ASH in Latin America, a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and classical hematology. April 25-26, 2025 Punta del Este Convention & Exhibition Center | Punta del Este, Uruguay Join the world’s leading hematology experts at Highlights of ASH in Latin America, a two-day program that highlights the most influential research pre sented at the latest

    Tweet Tweets with this article
    • It's your last chance to be part of this practice-changing weekend in Latin America! Learn the clinical applications of groundbreaking #ASH24 research in a small-meeting, interactive environment where you can get all your questions answered. Register: https://t.co/p9KFaF8CX3 https://t.co/RhaHgMjcin

  • Mashup Score: 20
    Highlights of ASH® - 3 month(s) ago

    Get a synopsis of the top hematology research presented at the latest ASH annual meeting and learn how it can help improve your patient management and care strategies at Highlights of ASH.

    Tweet Tweets with this article
    • Thanks to all who joined Highlights of ASH in the Mediterranean, Middle East, and North Africa! Learn the clinical applications of #ASH24 research in a small, interactive environment. Attend our final Highlights of ASH in Uruguay! https://t.co/1XPdxC35qv @b_avalos_MD @GCC_Cortes https://t.co/hJY9wp3jKf